PharmaShots | Incisive News in 3 Shots

Subscribe Now

kyowa kirin

Kyowa Kirin to Acquire Orchard Therapeutics for ~$477.6M

Kyowa Kirin to Acquire Orchard Therapeutics for ~$477.6M

October 5, 2023

Kyowa Kirin and MEI Pharma Reports P-II (MIRAGE) Study Results of Zandelisib for Indolent B-cell Non-Hodgkin’s Lymphoma in Japan

Kyowa Kirin and MEI Pharma Reports P-II (MIRAGE) Study Results of Zandelisib for Indolent B-cell Non-Hodgkin’s Lymphoma in Japan

November 21, 2022

PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia

PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues...

July 27, 2022

PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

June 4, 2021

Insights+ Key Biosimilars Events of June 2020

Insights+ Key Biosimilars Events of June 2020

July 3, 2020

PharmaShots Weekly Snapshot (Jun 15-19, 2020)

PharmaShots Weekly Snapshot (Jun 15-19, 2020)

June 22, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us